These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 1965139
21. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC. Cell Growth Differ; 1995 Jun; 6(6):655-63. PubMed ID: 7669719 [Abstract] [Full Text] [Related]
22. Effect of phorbol esters on the activity of purified transforming growth factors. Kraft AS. Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705 [Abstract] [Full Text] [Related]
23. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines. Zeinoun Z, Teugels E, De Bleser PJ, Neyns B, Geerts A, De Greve J. Anticancer Res; 1999 Apr; 19(1A):413-20. PubMed ID: 10226576 [Abstract] [Full Text] [Related]
26. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M. Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346 [Abstract] [Full Text] [Related]
27. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin. Dumont FJ, Kastner CA. J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294 [Abstract] [Full Text] [Related]
28. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Hafez MM, Infante D, Winawer S, Friedman E. Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877 [Abstract] [Full Text] [Related]
29. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Krasagakis K, Garbe C, Schrier PI, Orfanos CE. Anticancer Res; 1994 Dec; 14(6B):2565-71. PubMed ID: 7872682 [Abstract] [Full Text] [Related]
30. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Sun L, Wu S, Coleman K, Fields KC, Humphrey LE, Brattain MG. Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724 [Abstract] [Full Text] [Related]
31. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody. Suzuki T, Cooper MD. J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014 [Abstract] [Full Text] [Related]
32. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related]
33. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells. Kane S, Prentice MA, Mariano JM, Cuttitta F, Jakowlew SB. Anticancer Res; 2002 Feb; 22(3):1433-44. PubMed ID: 12168820 [Abstract] [Full Text] [Related]
34. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. Piacibello W, Severino A, Stacchini A, Aglietta M. Haematologica; 1991 Feb; 76(6):460-6. PubMed ID: 1820982 [Abstract] [Full Text] [Related]
35. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert HE, Gerharz CD. Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292 [Abstract] [Full Text] [Related]
36. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK. Cancer Res; 1995 Nov 01; 55(21):4892-8. PubMed ID: 7585526 [Abstract] [Full Text] [Related]
37. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Koli K, Keski-Oja J. Cancer Res; 1995 Apr 01; 55(7):1540-6. PubMed ID: 7882362 [Abstract] [Full Text] [Related]